ClinicalTrials.gg
Enrolling by invitationNCT05745129AID-SpineUpdated Feb 20, 2024

Applying Artificial Intelligence in Developing Personalized and Sustainable Healthcare for Spinal Disorders

An observational study in Low Back Pain, Neck Pain and Disc Herniation, sponsored by Oslo Metropolitan University. Enrolling by invitation at 1 site in Norway. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-02-20.

Sponsored by Oslo Metropolitan University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
165,000
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The primary objective is to use machine learning methods on large survey and health register data to identify participants with different treatment trajectories and health outcomes after surgical and/or conservative treatment for spinal disorders.

Secondary objectives are to 1) conduct external validation of the prediction models, and 2) explore how the prediction models can be implemented into AI-based clinical co-decision tools and interventions.

Read the detailed description

Three work packages are conducted. In the first, the investigators will use data from three general population surveys in Norway (HUNT, Tromsø, and Ullensaker) linked to administrative health registry data (Norwegian Patient Registry (for secondary care) and Norwegian Registry for Primary Health Care) and clinical registers on spinal disorders (the Norwegian registry for spine surgery, NorSpine, and the Norwegian registry for neck and back pain) to explore treatment trajectories and health outcomes following an episode of back and/or neck pain. The investigators will use different combinations of these data sets to assess the impact of a wide range of risk/ prognostic factors and to develop prognostic models for different health and welfare outcomes.

Four major outcomes will be adressed; a) unfavourable outcomes, b) use of prescribed medication, c) use of sickness absence and other disability benefits, and d) patient-reported outcomes.

In the second work package, the investigators will conduct external validation studies of the prediction models by using Danish and Swedish data. There is a large overlap and similarities in health and welfare registers across the Nordic countries.

In the third work package the investigators will first conduct a feasibility study in a secondary care hospital setting in which surgeons examine and assess referred patients with disc herniation and spinal stenosis for surgical treatment (or not). Qualitative interviews will be used to gain a better understanding of today's clinical decision-making process.

02

Conditions studied

  • Low Back Pain
  • Neck Pain
  • Disc Herniation
  • Disc Degeneration
  • Spinal Stenosis
  • Radiculopathy

Keywords

  • prognosis
  • trajectories
  • risk factors
  • prognostic factors
  • prognostic model
  • prediction model
  • health outcomes
  • work outcomes
03

In context

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's planned enrollment of 165,000 is above the median of 100 across 481 observational studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Oslo Metropolitan University is the lead sponsor of 64 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients referred to secondary care for assessment of surgery or not due to disc herniation (lumbar or cervical).

Eligibility criteria

Inclusion Criteria: patients referred to secondary care for assessment of surgery or not due to disc herniation (lumbar or cervical).

-

Exclusion Criteria: ambulant cases who needs immediate treatment

-

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
165,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Treatment cohort

    Surgical vs conservative treatment. Surgery procedures are based on the NOMESCO Classification of Surgical Procedures (NCSP). Conservative treatment includes all non-surgical treatment methods such as pharmaceutical treatment, physical medicine and physiotherapy modalities (information, patient education, exercise, manual therapy etc), cognitive-behavioural therapy, multidisciplinary treatment, acupuncture, and others (e.g. chiropractic treatment, homeopathy, naprapathy, osteopathy). The results will be described for important spinal subgroups (specific diagnoses, nerve-root affections, and non-specific conditions).

06

What researchers measure

Primary outcomes

  1. Patient-reported outcomes

    Patient-reported outcome measures included in clinical registers

    Time frame: depends upon the registry data, but in general between 2008 and 2022

  2. Unfavourable outcomes

    Healthcare utilization, reoperation, infection, or other complications after surgery.

    Time frame: depends upon the registry data, but in general between 2008 and 2022

  3. Prescribed medication

    High use of prescribed medication (dispensed drugs)

    Time frame: depends upon the registry data, but in general between 2008 and 2022

  4. Sickness absence

    Sickness absence and disability pension

    Time frame: depends upon the registry data, but in general between 2008 and 2022

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05745129
Lead sponsor
Oslo Metropolitan University
Responsible party
Margreth Grotle (Professor, Oslo Metropolitan University) — Principal investigator
First posted
Feb 27, 2023
Start date
Dec 1, 2021
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Feb 20, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion